1. Home
  2. Live Updates
  3. Brianm slomovitz

Brianm Slomovitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brianm slomovitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brianm Slomovitz Today - Breaking & Trending Today

Dr Slomovitz on the DUO-E and AtTEnd Trials Investigating Immunotherapy in Endometrial Cancer

Brian M. Slomovitz, MD, discusses the phase 3 DUO-E and AtTEnd trials investigating the use immunotherapy in endometrial cancer, as presented at the 2023 ESMO Congress. ....

Brianm Slomovitz , Cancer Research Committee , Florida International University , Mount Sinai Medical Center , Gynecologic Oncology , Mount Sinai , Onclive Tv , Gynecologic Oncology , Phase 3 Duoe Nct04269200 And Attend Nct03603184 ,

Dr Slomovitz on the Current Role of PARP Inhibitors in Ovarian Cancer

Brian M. Slomovitz, MD, discusses the optimal role for PARP inhibition in patients with ovarian cancer, highlighting its efficacy in those harboring BRCA mutations.
....

Brianm Slomovitz , Mount Sinai Medical Center , Cancer Research Committee , Florida International University , Gynecologic Oncology , Ovarian Cancer , Parp Inhibitors , Sylvester Annual Updates In Oncology ,

Selinexor Maintenance Improves PFS in TP53 Wild-Type Endometrial Cancer

Patients with TP53 wild-type endometrial cancer had longer progression-free survival when they received selinexor maintenance in a phase 3 trial. ....

United States , Miami Beach , Brianm Slomovitz , Mount Sinai Medical Center ,

Selinexor Maintenance Improves PFS in TP53 Wild-Type Endometrial Cancer

Patients with TP53 wild-type endometrial cancer had longer progression-free survival when they received selinexor maintenance in a phase 3 trial. ....

Miami Beach , United States , Brianm Slomovitz , Mount Sinai Medical Center ,

Selinexor Increases PFS for Endometrial Cancer With TP53 Mutations

Findings seen for maintenance therapy in patients with advanced or recurrent disease following response to systemic therapy. ....

United States , Miami Beach , Brianm Slomovitz , American Society For Clinical Oncology Plenary Series , Mount Sinai Medical Center , Healthday News , American Society , Clinical Oncology Plenary ,